Found 3 results
Name | Type of Offering | Accepted Date |
---|---|---|
ArriVent Biopharma, Inc.
|
D | 2022-12-29 11:39:51 |
Amount To Be Raised
$145,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001868279
Filed Document
0001868279-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-12-29 11:39:51
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ArriVent Biopharma, Inc.
|
D | 2021-06-23 16:20:04 |
Amount To Be Raised
$90,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001868279
Filed Document
0001868279-21-000002
Exclusions or Exemptions
506b
Accepted Date
2021-06-23 16:20:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ArriVent Biopharma, Inc.
|
D/A | 2022-02-14 14:52:30 |
Amount To Be Raised
$150,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001868279
Filed Document
0001868279-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-02-14 14:52:30
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|